Author:
Lasa-Saracíbar Beatriz,Aznar María Ángela,Lana Hugo,Aizpún Ismael,Gil Ana Gloria,Blanco-Prieto Maria J.
Funder
Caja Navarra Foundation
Spanish Ministry of Science and Innovation
Red Temática de Investigación Cooperativa en Cáncer
Fondo Europeo de Desarrollo Regional
Asociación de Amigos de la Universidad de Navarra
Reference18 articles.
1. Effects of nanomaterial physicochemical properties on in vivo toxicity;Aillon;Adv. Drug Deliv. Rev.,2009
2. Lipid nanoparticles for brain targeting. III. Long-term stability and in vivo toxicity;Blasi;Int. J. Pharm.,2013
3. Comparative study of A HPLC–MS assay versus an UHPLC–MS/MS for anti-tumoral alkyl lysophospholipid edelfosine determination in both biological samples and in lipid nanoparticulate systems;Estella-Hermoso de Mendoza;J. Chromatogr. B,2009
4. Estella-Hermoso de Mendoza, A., Blanco-Prieto, M.J., Campanero, M.A., Mollinedo, F., Villa-Pulgarín, J., Varela, R., 2011. Development and use of lipidic nanoparticles loaded with edelfosine and ether phospholipids in antitumoral and antiparasitic therapy. Spanish Patent, P201130433, October 3.
5. In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma;Estella-Hermoso de Mendoza;J. Control. Release,2011
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献